contraindicaciones de la l'carnitina L-Carnitina L CARNITINA BENEFICIOS E INCONVENIENTES

Disclosures: Binu John: Exact Sciences: Grant/Research Support, Genentech: Grant/Research Support, Glycotest, Inc: Grant/Research Support, Gilead: Grant/Research Support, Exelixis: Consultant, Takeda: Grant/Research Support, GlaxoSmithKline: Consultant, Astra Zeneca: Consultant, Dustin Bastaich: Nothing to Disclose, Catherine Mezzacappa: Nothing to Disclose, Raphaella Ferreira: Nothing to Disclose, Austen Hentschel: Nothing to Disclose, Andres Samos: Nothing to Disclose, Nadim Mahmud: Nothing to Disclose, Tamar Taddei: Nothing to Disclose, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support, Bassam Dahman: Nothing to Disclose 2073 HYDROPHOBIC SECONDARY BILE ACIDS INDUCE PRIMARY SCLEROSING CHOLANGITIS THROUGH THE LIVER-LARGE INTESTINE AXIS IN A CYP2C70 -/- / CYP2A12 -/- MOUSE WITH HUMAN-TYPE BILE ACID COMPOSITION -/- -/- Teruo Miyazaki 1 Hajime Ueda 1 Tadashi Ikegami 1 Akira Honda 1 , 1 Tokyo Medical University Ibaraki Medical Center Background: Primary sclerosing cholangitis (PSC) is characterized by fibrosis around the large bile duct (onion-skin lesions) and frequently complicates inflammatory bowel diseases (IBD)

Elevated homocysteine (Hcy) levels induce oxidative stress and are considered an independent risk factor for AMI

GRP did not promote anoikis resistance in male Ecad (1062) or female Ecad (1014) cells (Extended Data Fig

Multiple human and non-human cell lines are available with epithelial or non-epithelial origins

An increased V d would tend to prolong clearance time